Population, general practitioner and practice characteristics are associated with screening procedures for microvascular complications in Type 2 diabetes care in Norway.


Journal

Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858

Informations de publication

Date de publication:
11 2019
Historique:
accepted: 18 10 2018
pubmed: 22 10 2018
medline: 29 7 2020
entrez: 22 10 2018
Statut: ppublish

Résumé

To assess population, general practitioner (GP) and practice characteristics associated with the performance of microvascular screening procedures and to propose strategies to improve Type 2 diabetes care. A cross-sectional survey in Norway (281 GPs from 77 practices) identified 8246 people with a Type 2 diabetes duration of 1 year or more. We used multilevel regression models with either the recording of at least two of three recommended screening procedures (albuminuria, monofilament, eye examination) or each procedure separately as dependent variable (yes/no), and characteristics related to the person with diabetes, GP or practice as independent variables. The performance of recommended screening procedures was recorded in the following percentages: albuminuria 31.5%, monofilament 27.5% and eye examination 60.0%. There was substantial heterogeneity between practices, and between GPs within practices for all procedures. Compared with people aged 60-69 years, those aged < 50 years were less likely to have an albuminuria test performed [odds ratio (OR) 0.75, 95% CI 0.61 to 0.93] and eye examination (OR 0.79, 95% CI 0.66 to 0.95). People with macrovascular disease had fewer screening procedures recorded (OR 0.68, 95% CI 0.59 to 0.78). Use of an electronic diabetes form was associated with improved screening  (OR 2.65, 95% CI 1.86 to 3.78). GPs with high workload recorded fewer procedures (OR 0.59, 95% CI 0.39 to 0.90). Performance of screening procedures was suboptimal overall, and in people who should be prioritized. Performance varied substantially between GPs and practices. The use of a structured diabetes form should be mandatory.

Identifiants

pubmed: 30343522
doi: 10.1111/dme.13842
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1431-1443

Informations de copyright

© 2018 Diabetes UK.

Références

10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018; 41(Suppl 1): S105-S118.
Helsedirektoratet. Nasjonal faglig retningslinje for diabetes 2016. Available at https://helsedirektoratet.no/retningslinjer/diabetes Last accessed 1 August 2018.
National Institute for Health and Care Excellence. Type 2 Diabetes in Adults: Management [NG28]. Available at https://www.nice.org.uk/guidance/ng28/chapter/1-Recommendations Last accessed 1 August 2018.
Brownrigg JR, Hughes CO, Burleigh D, Karthikesalingam A, Patterson BO, Holt PJ et al. Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrin 2016; 4: 588-597.
Bakris GL, Molitch M. Microalbuminuria as a risk predictor in diabetes: the continuing saga. Diabetes Care 2014; 37: 867-875.
Fung CS, Wan EY, Chan AK, Lam CL. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study. BMC Nephrol 2017; 18: 47.
Scanlon PH, Aldington SJ, Stratton IM. Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy. Diabet Med 2014; 31: 439-442.
Crawford F, Cezard G, Chappell FM, Murray GD, Price JF, Sheikh A et al. A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). Health Technol Assess 2015; 19: 1-210.
Bakke A, Cooper JG, Thue G, Skeie S, Carlsen S, Dalen I et al. Type 2 diabetes in general practice in Norway 2005-2014: moderate improvements in risk factor control but still major gaps in complication screening. BMJ Open Diabetes Res care 2017; 5: e000459.
Healthcare Quality Improvement Partnership. National Diabetes Audit 2015. Available at http://www.hqip.org.uk/resources/national-diabetes-audit-2013-2014-2014-2015-report-1-care-processes-and-treatment-targets/ Last accessed 1 August 2018.
Nationella Diabetesregistret. Nationella Diabetesregistret 2014. Available at https://www.ndr.nu/pdfs/Arsrapport_NDR_2014.pdf Last accessed 1 August 2018.
Scottish Diabetes Survey 2014. Scottish Diabetes Survey 2014. Available at http://www.diabetesinscotland.org.uk/Publications/SDS2014.pdf Last accessed 1 August 2018.
Calvert M, Shankar A, McManus RJ, Lester H, Freemantle N. Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study. BMJ 2009; 338: b1870.
Guldberg TL, Lauritzen T, Kristensen JK, Vedsted P. The effect of feedback to general practitioners on quality of care for people with type 2 diabetes. A systematic review of the literature. BMC Fam Pract 2009; 10: 30.
Welch G, Allen NA, Zagarins SE, Stamp KD, Bursell SE, Kedziora RJ. Comprehensive diabetes management program for poorly controlled Hispanic type 2 patients at a community health center. Diabetes Educ 2011; 37: 680-688.
Wong CKH, Fung CSC, Yu EYT, Wan EYF, Chan AKC, Lam CLK. Temporal trends in quality of primary care for patients with type 2 diabetes mellitus: a population-based retrospective cohort study after implementation of a quality improvement initiative. Diabetes Metab Res Rev 2018; 34 https://doi.org/10.1002/dmmr.2952.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
Austin PC, Merlo J. Intermediate and advanced topics in multilevel logistic regression analysis. Stat Med 2017; 36: 3257-3277.
Moreton RBR, Stratton IM, Chave SJ, Lipinski H, Scanlon PH. Factors determining uptake of diabetic retinopathy screening in Oxfordshire. Diabet Med 2017; 34: 993-999.
Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbjornsdottir S et al. Excess mortality among persons with Type 2 diabetes. N Engl J Med 2015; 373: 1720-1732.
Azam M, Marwood L, Ismail K, Evans T, Sivaprasad S, Winkley K et al. Diabetes complications at presentation and one year by glycated haemoglobin at diagnosis in a multiethnic and diverse socioeconomic population: results from the South London Diabetes Study. J Diabetes Res 2015; 2015: 587673.
Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 2011; 34: 145-150.
Sandbaek A, Griffin SJ, Sharp SJ, Simmons RK, Borch-Johnsen K, Rutten GE et al. Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study. Diabetes Care 2014; 37: 2015-2023.
Guldberg TL, Vedsted P, Kristensen JK, Lauritzen T. Improved quality of Type 2 diabetes care following electronic feedback of treatment status to general practitioners: a cluster randomized controlled trial. Diabet Med 2011; 28: 325-332.
Barkhuysen P, de Grauw W, Akkermans R, Donkers J, Schers H, Biermans M. Is the quality of data in an electronic medical record sufficient for assessing the quality of primary care? J Am Med Inform Assoc 2014; 21: 692-698.
Helsedirektoratet. Fastlegeres tidsbruk 2018. Available at https://www.regjeringen.no/no/dokumenter/fastlegers-tidsbruk/id2592992/ Last accessed 1 August 2018.
Lenz ER, Mundinger MO, Hopkins SC, Lin SX, Smolowitz JL. Diabetes care processes and outcomes in patients treated by nurse practitioners or physicians. Diabetes Educ 2002; 28: 590-598.
Petek D, Mlakar M. Quality of care for patients with diabetes mellitus type 2 in ‘model practices’ in Slovenia - first results. Zdravstveno varstvo 2016; 55: 179-184.
Hallgren Elfgren IM, Tornvall E, Grodzinsky E. The process of implementation of the diabetes register in primary health care. Int J Qual Health Care 2012; 24: 419-424.
Vamos EP, Pape UJ, Bottle A, Hamilton FL, Curcin V, Ng A et al. Association of practice size and pay-for-performance incentives with the quality of diabetes management in primary care. CMAJ 2011; 183: E809-E816.

Auteurs

Å Bakke (Å)

Department of Medicine, Stavanger University Hospital, Stavanger.
Department of Global Public Health and Primary Care, University of Bergen, Bergen.

A T Tran (AT)

Department of General Practice, Institute of Health and Society, University of Oslo, Oslo.

I Dalen (I)

Department of Research, Section of Biostatistics, Stavanger University Hospital, Stavanger.

J G Cooper (JG)

Department of Medicine, Stavanger University Hospital, Stavanger.
Norwegian Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital, Bergen.

K F Løvaas (KF)

Norwegian Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital, Bergen.

A K Jenum (AK)

General Practice Research Unit (AFE), Department of General Practice, Institute of Health and Society, University of Oslo, Oslo.

T J Berg (TJ)

Institute of Clinical Medicine, University of Oslo, Oslo.
Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo.

T V Madsen (TV)

Norwegian Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital, Bergen.

K Nøkleby (K)

Department of General Practice, Institute of Health and Society, University of Oslo, Oslo.

B Gjelsvik (B)

Department of General Practice, Institute of Health and Society, University of Oslo, Oslo.

T Claudi (T)

Nordland Hospital, Department of Medicine, Bodø.

S Skeie (S)

Department of Medicine, Stavanger University Hospital, Stavanger.
Department of Clinical Science, University of Bergen, Bergen, Norway.

S Carlsen (S)

Department of Medicine, Stavanger University Hospital, Stavanger.
Norwegian Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital, Bergen.

S Sandberg (S)

Department of Global Public Health and Primary Care, University of Bergen, Bergen.
Norwegian Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital, Bergen.
Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway.

G Thue (G)

Department of Global Public Health and Primary Care, University of Bergen, Bergen.
Norwegian Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital, Bergen.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH